Open AccessRelapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report
Author(s) -
Xuanfeng Ding,
Lan Mi,
Yuqin Song,
Weiping Liu,
Hui Yu,
Ningjing Lin,
Jun Zhu
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i21.6041
Subject(s) - medicine , decitabine , refractory (planetary science) , lymphoma , hodgkin lymphoma , oncology , biochemistry , gene expression , chemistry , physics , astrobiology , dna methylation , gene